The Latest Cardiac and Vascular News
MINNEAPOLIS, March 21, 2022 /PRNewswire/ — The use of medications and exercise is more beneficial in preventing a second stroke in people with intracranial atherosclerosis than placing a stent in the blood vessel, according to a new practice advisory issued by the American Academy of Neurology (AAN). The practice advisory is published in the March 21, […]
New Procedure Reimbursement Code Expected to Enhance Study Performance for Clinical Centers Participating in the CardiAMP Cell Therapy Heart Failure Trial and the CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial SUNNYVALE, Calif., March 22, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment […]
Successfully completed all testing; plan to re-submit FUROSCIX® NDA by April 15, 2022 Commercial preparedness activities ramping up to support anticipated Q4 2022 launch of FUROSCIX, if approved Presented key FREEDOM-HF secondary endpoint data at the Cardiovascular Research Foundation Technology and Heart Failure Therapeutics Conference 2022 Ended Q4 with cash, cash […]
BrigHtn Phase 2 study with CIN-107 for Resistant Hypertension Enrollment Complete with Topline Results Expected in 2H 2022 Topline Data from HALO Phase 2 study with CIN-107 for Uncontrolled Hypertension Expected in 2H 2022 Mason Freeman, M.D. named Chief Medical Officer Conference call and live webcast today at 8:30 AM […]
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: Valbiotis (Paris:ALVAL) (FR0013254851 – ALVAL, eligible for PEA / SME), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, is strengthening its commitment to Corporate Social Responsibility (CSR) by joining the United Nations Global Compact and applying […]
BURLINGTON, Mass., March 21, 2022 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it has joined the NASDAQ US Broad Dividend Achievers Index. The index is comprised of US securities with at least ten consecutive years of increasing annual regular dividend payments. […]
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) — Recora today emerged from stealth to announce $20M in Series A funding while also unveiling Recora’s Cardiac Recovery Program for health systems, medical groups and health plans. The heavily oversubscribed round was led by SignalFire with participation from Valor Equity Partners and existing investor Pear […]
The ZOLL Arrhythmia Management System (AMS) mobile cardiac telemetry (MCT) solution adds biometric data to traditional MCT data, helping physicians make more informed treatment plans CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced the launch of the ZOLL Arrhythmia Management […]
Acquisition to Enhance Cardiovascular Expertise and Regional Presence in Europe TOLEDO, Ohio & MADRID–(BUSINESS WIRE)–NAMSA, a world leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its intent to acquire ÅKRN Scientific Consulting, a prominent European Medical Device CRO based in Madrid, Spain. ÅKRN, founded in 2018, […]
A Mobile Roadshow Designed to Showcase the Future of Medical Imaging The mobile exhibition will bring Canon Medical Systems to U.S. cities providing unprecedented access to their solution-focused portfolios TUSTIN, Calif.–(BUSINESS WIRE)–Canon Medical Systems USA, Inc. (CMSU), a global leader in innovative diagnostic imaging technology, is proud to announce its […]
